First City Capital Management, Inc. Bio Techne Corp Transaction History

First City Capital Management, Inc.

$186 Million
Q4 2024

A detailed history of First City Capital Management, Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, First City Capital Management, Inc. holds 2,950 shares of TECH stock, worth $189,449. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,950

Previous 2,950 -0.0%

Holding current value

$189,449

Previous $235,000 9.79%

% of portfolio

0.11%

Previous 0.12%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$62.12 - $84.15 $14,598 - $19,775	-235 Reduced 7.38%	2,950 $211,000
Q1 2024 May 22, 2024	BUY	$65.98 - $77.09 $12,206 - $14,261	185 Added 6.17%	3,185 $224,000
Q4 2023 Feb 07, 2024	SELL	$52.83 - $78.22 $5,283 - $7,822	-100 Reduced 3.23%	3,000 $231,000
Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $187,557 - $819,074	2,325 Added 300.0%	3,100 $256,000
Q2 2022 Jul 21, 2022	SELL	$322.67 - $449.65 $11,293 - $15,737	-35 Reduced 4.32%	775 $269,000
Q4 2021 Feb 07, 2022	SELL	$456.15 - $525.06 $15,965 - $18,377	-35 Reduced 4.14%	810 $332,000
Q3 2021 Oct 28, 2021	SELL	$444.87 - $538.88 $22,243 - $26,944	-50 Reduced 5.59%	845 $409,000
Q1 2021 May 13, 2021	SELL	$314.62 - $411.0 $34,608 - $45,210	-110 Reduced 10.95%	895 $366,000
Q4 2020 Feb 12, 2021	SELL	$246.9 - $321.87 $187,644 - $244,621	-760 Reduced 43.06%	1,005 $397,000
Q3 2020 Nov 16, 2020	BUY	$232.22 - $282.96 $123,076 - $149,968	530 Added 42.91%	1,765 $437,000
Q2 2020 Aug 14, 2020	BUY	$185.43 - $279.56 $229,006 - $345,256	1,235 New	1,235 $326,000

Others Institutions Holding TECH

# of Institutions

615

Shares Held

156M

Call Options Held

161K

Put Options Held

12.7K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.52B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First City Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First City Capital Management, Inc. with notifications on news.

Account

First City Capital Management, Inc. Bio Techne Corp Transaction History